MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1073/pnas.2610397123

Медицинская библиотека · Proceedings of the National Academy of Sciences of the United States of America · 2026

Mechanisms of von Willebrand factor activation driving no reflow in ischemic stroke.

Laroche Audrée, Rovito Nick, Liu Alice, Allaeys Isabelle, Heitsch Laura, Portier Irina, Adeoye Opeolu, Pizzella Stephanie R, Giles James A, Di Paola Jorge, Lee Jin-Moo, Bark David, Campbell Robert A, Mukherjee Debanjan, Boilard Éric, Denorme Frederik

СтатьяПеревод пока не подготовлен

Аннотация

Rapid restoration of cerebral blood flow is the cornerstone of acute ischemic stroke treatment. Endovascular thrombectomy achieves substantial reperfusion in 90% of patients with large-vessel occlusion stroke; however, almost half of treated patients continue to have significant disability despite successful thrombus removal. Transient periods of ischemia can trigger microvascular thrombosis resulting in the no-reflow phenomenon. Yet the molecular and hemodynamic triggers underlying no reflow remain poorly defined. Using a murine model of transient ischemic stroke combined with intravital imaging, we visualized platelet-von Willebrand factor (VWF) thrombi forming in penumbral tissue where blood flow dynamics were altered in response to the original ischemic insult. In silico modeling based on our intravital observations indicated that the altered, converging blood flow in these vessels increases local elongational flow, a condition that can favor VWF unfolding. The activity of VWF is controlled by ADAMTS13, which cleaves VWF. We further identified that in the acute phase of stroke, locally released IL-6 suppresses ADAMTS13-mediated cleavage of VWF, creating a prothrombotic imbalance that promotes microvascular thrombosis and worsens outcomes in mice. In ischemic stroke patients, we observed an acute increase in IL-6 that correlated strongly with increased VWF activity. VWF activity was highest in patients experiencing worse outcomes. Inhibition of IL-6 in ex vivo stroke patient plasma restored ADAMTS13 activity. Together, these findings reveal how hemodynamic and inflammatory factors converge to favor VWF activation in the reperfused brain and contribute to the development of no reflow in ischemic stroke.

Для цитирования: Laroche Audrée, Rovito Nick, Liu Alice, Allaeys Isabelle, Heitsch Laura, Portier Irina, Adeoye Opeolu, Pizzella Stephanie R, Giles James A, Di Paola Jorge, Lee Jin-Moo, Bark David, Campbell Robert A, Mukherjee Debanjan, Boilard Éric, Denorme Frederik. Mechanisms of von Willebrand factor activation driving no reflow in ischemic stroke.. Proceedings of the National Academy of Sciences of the United States of America. 2026. DOI: 10.1073/pnas.2610397123.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.